Induction Phase

DRUG2 trials

Sponsors

Andres J. M. Ferreri, SWOG Cancer Research Network

Conditions

Burkitt's LymphomaCD19+ Acute LeukemiaHIVPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase 2

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

CompletedNCT01516593

Andres J. M. FerreriBurkitt's Lymphoma, HIV

Start: 2011-11-30End: 2015-08-31Updated: 2022-08-04

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Enrolling by invitationNCT06773936

SWOG Cancer Research NetworkCD19+ Acute Leukemia, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Start: 2026-05-15End: 2033-07-01Target: 55Updated: 2026-03-04